Journals / Klinik Tıp Pediatri Dergisi / 2016 / Cilt: 8 - Sayı: 3

Outpatient Treatment of Community-AcquiredPneumonia in Children

Çocukluk Çağında Toplum KökenliPnömoninin Ayaktan Tedavisi

Pages
17–24
Publication Date
2016-05-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, the most common pathogens, diagnostic criteria and empirical and agentspecific outpatient treatment options for pediatric patientsdiagnosed with community-acquired pneumonia with noindication of hospitalization have been described.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AbstractCommunity-acquired pneumonia (CAP) is a public health problem all over theworld, that is a significant cause of respiratory morbidity and mortality especiallyin children under age 5 living in developing countries.
📊
Key Findings & Data:CAP is the leading cause of death worldwide in children younger than 5 years old.Clinical findings of the patients are important in the diagnosis of CAP in children.
💡
Conclusion & Impact:In this article, the most common pathogens, diagnostic criteria and empirical and agentspecific outpatient treatment options for pediatric patientsdiagnosed with community-acquired pneumonia with noindication of hospitalization have been described.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Antimikrobiyal · ayaktan · çocuk

Abstract

AbstractCommunity-acquired pneumonia (CAP) is a public health problem all over theworld, that is a significant cause of respiratory morbidity and mortality especiallyin children under age 5 living in developing countries. CAP is the leading cause of death worldwide in children younger than 5 years old.Clinical findings of the patients are important in the diagnosis of CAP in children. Common symptoms include fever, tachypnea, increased respiratory effort, rhonchi, crackles and wheezing. Hydration status, activity level and oxygen saturation ofthe patient are also important and may indicate the need for hospitalization.The outpatient administration of empirical oral antimicrobial treatment is oftenplanned in order to provide an effective treatment against the bacterial pathogens thatare the most common causes of lower respiratory tract infection and especially against S. pneumoniae, a bacterial pathogen, which if untreated or inadequately treated, can cause severe sequels. In this article, the most common pathogens, diagnostic criteria and empirical and agentspecific outpatient treatment options for pediatric patientsdiagnosed with community-acquired pneumonia with noindication of hospitalization have been described.

Özet

ÖzToplum kökenli pnömoni (TKP) tüm dünyada özellikle gelişmekte olan ülkelerde yaşayan 5 yaşın altındaki çocuklarda önemli düzeyde solunumsal morbidite vemortalite nedeni olan bir halk sağlığı sorunudur. TKP dünya çapında 5 yaşından küçük çocuklarda önde gelen ölüm nedenidir. Çocuklarda TKP tanısında hastaların klinik bulguları önemlidir. Sık rastlanan bulgular arasında ateş, takipne, artmış solunum çabası, ronkuslar, raller ve vizing yeralır. Hidrasyon durumu, aktivite düzeyi ve oksijen satürasyonu da önemlidir ve hastaneye yatma ihtiyacını gösterebilir.Ayaktan verilen ampirik oral antimikrobiyal tedavi alt solunum yolu enfeksiyonlarının en sık nedeni olan bakteriyel patojenlere ve özellikle de tedavi edilmediğinde veya yetersiz tedavide ağır sekele yol açabilecek bir bakteriyel patojen olan S. pneumoniae’ya karşı etkili bir tedavi sağlamaya yönelik olarak planlanmaktadır. Bu yazıda toplum kökenli pnömoni tanısı konulan ancak hastaneye yatış endikasyonu ol-mayan çocuk hastalarda en sık rastlanan etkenler, tanı kriterleri ve ampirik ve etkene yönelik ayaktan tedavi seçenekleri anlatılmıştır.

🔖

Cite This Article

ÇELİK, U. D. M. (2016). Outpatient Treatment of Community-AcquiredPneumonia in Children. Klinik Tıp Pediatri Dergisi, Cilt: 8 - Sayı: 3, 17–24. https://ajindex.com/articles/838458

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Kaynaklar 1.Schauner S, Erickson C, Fadare K, Stephens K. Community-ac-quired pneumonia in children: a look at the IDSA guidelines. JFam Pract 2013
  2. 62 (1): 9-15. 2.Black RE, Cousens S, Johnson HL, et al.
  3. Child Health Epide-miology Reference Group of WHO and UNICEF. Global, regio-nal, and national causes of child mortality in 2008: a systema-tic analysis. Lancet 2010
  4. 375 (9730): 1969-87. 3.Jadavji T, Law B, Lebel MH, Kennedy WA, Gold R, Wang EE.A practical guide for the diagnosis and treatment of pediatric pneu-monia. CMAJ 1997
  5. 156 (5): S703-S711. 4.Kumar S, Wang L, Fan J, et al. Detection of 11 common viral andbacterial pathogens causing community-acquired pneumonia orsepsis in asymptomatic patients by using a multiplex reverse trans-cription-PCR assay with manual (enzyme hybridization) or au-tomated (electronic microarray) detection. J Clin Microbiol 2008
  6. 46 (9): 3063-72. 5.Michelow IC, Olsen K, Lozano J, et al. Epidemiology and clini-cal characteristics of community-acquired pneumonia in hospi-talized children. Pediatrics 2004
  7. 113 (4): 701-707. 6.Williams JV, Harris PA, Tollefson SJ, et al. Human metapneu-movirus and lower respiratory tract disease in otherwise healthyinfants and children. N Engl J Med 2004
  8. 350 (5): 443-50. 7.Cincinnati Children’s Hospital Medical Center. Evidence-basedcare guideline. Community acquired pneumonia in children 60days through 17 years of age. http://www.cincinnatichildrens.org/service/j/ anderson-center/ evidence-based-care/ community-acquired-pneumonia. Accessed February 14, 2012. 8.Black S, Shinefield H, Baxter R, et al. Postlicensure surveillan-ce for pneumococcal invasive disease after use of heptavalent pneu-mococcal conjugate vaccine in Northern California Kaiser Per-manente. Pediatr Infect Dis J 2004
  9. 23 (6): 485-89. 9.Kallen AJ, Reed C, Patton M, Arnold KE, Finelli L, Hageman J.Staphylococcus aureus community-onset pneumonia in patientsadmitted to children’s hospitals during autumn and winter of 2006-2007. Epidemiol Infect 2010
  10. 138 (5): 666-72. 10.Stankovic C, Mahajan PV, Asmar BI. Methicillin-resistantStaphylococcus aureus as a cause of community-acquired pneu-monia. Curr Infect Dis Rep 2007
  11. 9 (3): 223-27. 11.Finelli L, Fiore A, Dhara R, et al. Influenza-associated pediat-ric mortality in the United States: increase of Staphylococcus au-reus coinfection. Pediatrics 2008
  12. 122 (4): 805-11. 12.Hageman JC, Uyeki TM, Francis JS, et al. Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 in-